Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Comparative characterization of CD271 + and CD271 - subpopulations of CD34 + human adipose-derived stromal cells.

Beckenkamp LR., Souza LEB., Melo FUF., Thomé CH., Magalhães DAR., Palma PVB.

Laboratory Study on Face & Skin, published in J Cell Biochem (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
J Cell Biochem (2018)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
29125884
DOI
10.1002/jcb.26496
Citations
23

Abstract (original English)

Adipose-derived stromal/stem cells (ASCs) are promising candidates for cell-based therapies. However, the lack of markers able to unequivocally identify these cells, the differential expression of cell surface molecules among stromal progenitors from different tissues and cellular alterations caused by culture are phenomena that need to be comprehensively addressed in order to improve ASC purification and consequently refine our knowledge about their function and therapeutic efficiency. In this study, we investigated the potential of CD271, a marker used for purification of bone marrow-derived mesenchymal stem cells, on enriching ASCs from CD34 + stromal cells of human adipose tissue. Putative ASC populations were sorted based on CD271 expression (CD45 - CD31 - CD34 + CD271 + and CD45 - CD31 - CD34 + CD271 - cells) and compared regarding their clonogenic efficiency, proliferation, immunophenotypic profile, and multilineage potential. To shed light on their native identity, we also interrogated the expression of key perivascular cell markers in freshly isolated cells. CD271 - cells displayed twofold higher clonogenic efficiency than CD271 + cells. Upon culture, the progeny of both populations displayed similar immunophenotypic profile and in vitro adipogenic and chondrogenic potentials, while CD271 + cells produced more calcified extracellular matrix. Interestingly, uncultured f

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAdultAntigens, CD34FemaleGene Expression RegulationHumansMaleNerve Tissue ProteinsReceptors, Nerve Growth FactorStromal Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research